SCOTT R. VILLWOCK

President and CEO
 

At the helm of Stramsen Biotech Inc. stands our distinguished President & CEO, Mr. Scott R. Villwock, a U.S. Military Veteran whose exceptional background uniquely positions him to lead our innovative biopharmaceutical company. With a Bachelor of Science Degree in Business Management from the University of Maryland and an Associate of Arts Degree in Logistics Management from the College of the Air Force, Mr. Villwock brings a robust educational foundation to his role.

​

Mr. Villwock's journey began with six years of dedicated service in the United States Air Force, where he honed his skills as a Logistics Specialist both domestically and in Europe. Following his honorable discharge, he seamlessly transitioned to the private sector, amassing invaluable experience across a diverse range of industries including Food & Beverage, Packaging, Corrugated, Steel, Electronics, Oil & Gas, Consumer Goods, and Waste, as well as the Non-Profit Arena.

​

His illustrious career includes senior executive roles in Operations and Supply Chain with two Fortune 100 giants, Amazon and Exxon Mobil. Mr. Villwock's leadership prowess is evident in his successful management of teams exceeding 700 employees, demonstrating his ability to inspire and guide large-scale operations effectively.

​

Drawing from his extensive logistics and operations experience, Mr. Villwock has cultivated a wealth of knowledge that enables him to steer Stramsen Biotech Inc. towards its fullest potential. His passionate commitment to safety and his aptitude for solving complex problems are complemented by his strategic approach to leveraging people, systems, processes, and procedures to achieve outstanding results in a data-driven environment.
 

Mr. Villwock's expertise extends to managing multi-site startup operations and implementing successful turnarounds for both departments and entire companies. This unique blend of skills positions him perfectly to guide Stramsen Biotech Inc. through the challenging landscape of biopharmaceutical innovation, ensuring we remain at the forefront of developing transformative, plant-based medicines that have the potential to revolutionize patient care.

​